輝瑞製藥(Pfizer) 宣布調低肺炎疫苗價格

第一步 

Today after years of negotiation, Pfizer finally announced that it was reducing the price of its pneumococcal conjugate vaccine, Prevenar 13, (PCV13) to 3.10 per dose (US$ 9.30 per child for all three doses) for humanitarian organizations working in emergency settings. This is definitely a step in the right direction and will help to protect millions of vulnerable children around the world and in MSF projects.